I agree with "noise". Since there is no news, this static pushes the stocks around. Nothing has changed and we are still waiting for results. Should be around $112 - $120 until we get closer to Epidiolex data.
Pretty much nailed it there Mr Bigs, not something you can read up on in five minutes. We are tracking the IBB, which looks ready for another drop, Death cross still in effect IMO.
Hillary+election year politics +program trading+hedge funds+October noise+plus late comer traders bailing out + shaky investors like me= drop trousers and wait until the log stops rolling
You should be well aware of the reasons, if you do reasonable research / DD. It is no surprise to me. There are numerous reasons, and few reasons to think it will get any better soon. The party is over (for now) , wake up and smell the proverbial coffee.
Biotechs are getting hammered. Clearly this is oversold but may continue to drop a bit more. My guess is we bounce around in the 80's for a while. Once we get some more good news we will be 100+ again. This is a great opportunity to build your position with more shares.
Sentiment: Strong Buy
Why don't you do your own research and stop believing Wall Street analyst that have a hidden agenda. Look what happened to your purchase of JCP. Their opinions can't be trusted.
I've tried all sorts of stock picking newsletters and PennyStock101 (org) is hands down the best. Just do a google or yahoo search and sign up for the newsletter while its still free.
I agree with you. GW pipline is great is a longer term winner. I can stand hedge fund resistance, and the volatility you can expect with a stock like this but when the hedge funds and politicans back into an uholy alliance, I am exit stage left, but monitoring. I have seen postive remedial effects of pot for years in Colorado so the formalization is a for sure but it has haters and that makes it somewhat unique and ultra risky and volatile. Good luck Mr. Doobie!
parts of your argument I agree with mr Bigs, to a degree, but GW have a vast untapped potential pipeline, dont listen to the naysayers that cannabis is not effective, it is, but there is still much resistance to cannabinoid therapy from some doctors, doctors than frankly dont do enough research, this next month might see a further drop, but once we get out of October the only way is up IMO, I do think that there might be a sell off around FDA approval, but we can deal with that when we get there, good luck to all longs, grab bargains when you can, I would love to see this drop lower, just to buy more shares....
I only asked because you projected " If your outlook is 4 to 5 years then this willl be an winner". Are you projecting, or aren't you? It doesn't matter how many sellers there are if there are buyers to match. The stock is relative to no other, so I'm sticking with the winner part.
I am out so dont have to project anymore. A better question might be how many sellers will there be before the FDA approval. I think the stock is a winner but relative to what?
If Epidiolex passes phase 3 trials and is approved by the FDA next year, do you think that investors will wait 4 - 5 years before they buy?
you are likely correct on your logic but logic is not ruling this biotech market nor will it over the longer term. Politics rule and history supports this. This will be a headline issue for Democrats and shorts will feast. I think you are right over the long term but it is long term and meaning years. Politicians from both parties continue to destroy makets for thier own gains. This is just my opiinion but it happened when Bill Clnton took on healh care prices and it chilled the market for years. I am just not willing to wait that long. Look at insider trading and Merrril Lynch history. Good Luck and I want you to be right.
GW doesn't need to overprice. All they need is acceptance - and not just FDA approval. Because cannabinoids have a great safety profile, they should be first line treatment for many indications. They could sell a large volume of product. That's why I own the stock.